varicella zoster virus MAbs (Teijin)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namevaricella zoster virus MAbs (Teijin)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsVaricella Zoster Virus Infection
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTeijin Pharma
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTeijin Pharma
Active IndicationsN/A
Inactive IndicationsVaricella Zoster Virus Infection

Other Information

ATC CodeN/A
Related LinksN/A